Soyxidil 2in1 Treatment 265ml
- hair treatment
2-in-1 Treatment for Hair and Scalp
Medicube Soyxidil 2in1 Treatment is a treatment designed to care for both the hair and scalp in a single step. The product is positioned as a nourishing anti-hair loss treatment, and its formula is intended to support the condition of the hair follicles, improve the appearance of the lengths, and care for scalp comfort at the same time. It is a solution for people who want to combine strengthening care with daily hair smoothing.
Key Benefits for Hair
- supports the care of weakened hair prone to excessive shedding,
- helps strengthen hair from the roots to the ends,
- smooths the strands and makes them easier to detangle,
- helps improve softness and the overall appearance of the hairstyle,
- works on both the hair and the scalp at the same time.
Formula Developed for Strengthening Care
Product descriptions emphasize the presence of the patented SoyACT complex derived from black soybeans, as well as biotin, Copper Tripeptide-1, and ingredients that support the hair and scalp. The treatment also contains hydrolyzed plant proteins, which help care for the hair structure, smooth its surface, and reduce roughness. As a result, the product addresses not only the needs of the scalp, but also the expectations of those who want hair that looks more cared for, feels softer, and is easier to style.
Convenient Application and Daily Use
This is a 2-in-1 treatment that can be used as a product for both the hair and scalp. Upon contact with water, the lightweight texture transforms into a creamy emulsion, which helps ensure even distribution. An additional advantage is the applicator, which makes precise application at the roots easier.
- Apply to clean, damp hair.
- Distribute from the scalp through the lengths.
- Use as part of a regular strengthening care routine.
If you are looking for a hair treatment that combines caring, smoothing, and supportive action for weakened hair, this 2-in-1 variant will be a practical choice for your daily routine.